Carnitine-acylcarnitine Translocase (CACT) Deficiency
1 clinical trials · Condition
◉ Watch Carnitine-acylcarnitine Translocase (CACT) Deficiency
| Record | Firm | Date |
|---|---|---|
| Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin Studies (NCT02214160) | Ultragenyx Pharmaceutical Inc | 2014-12-09 |
Track Carnitine-acylcarnitine Translocase (CACT) Deficiency automatically
Every clearance here is in the API, with alerts when new ones post.